ARCHIVE

• CORPORATE ROUNDUP NEWS IN BRIEF
  October 13, 2003

• Sugi Yakkyoku: Strong Growth in 1st-half Sales, Profits
  October 13, 2003

• PRESS SEMINAR
  October 13, 2003

• Asahi Kasei Pharma Aims for Sales of \160 Bil. in FY2008
  October 13, 2003

• NEW PRODUCTS
  October 13, 2003

• Novartis Pharma Begins to Independently Market Zaditen
  October 13, 2003

• Simvastatin Useful in Patients with Diabetic Complications
  October 13, 2003

• Dainippon Aims to Boost MR Effectiveness via IT Solutions
  October 13, 2003

• Fibrates Effective against Lipid Metabolism Disorders: Kaken
  October 13, 2003

• MPC to Spin off Ethical Drug Manufacturing Division
  October 13, 2003

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  October 13, 2003

• BUSINESS NEWS IN BRIEF
  October 13, 2003

• Bacterial Screening Also Essential for Platelet Products: bioMerieux
  October 13, 2003

• GSK's Epivir Gets Add. Formulation: CDFS Panel
  October 13, 2003

• DIAGNOSTIC NEWS IN BRIEF
  October 13, 2003

• Kirin's Busulfan Designated as Orphan
  October 13, 2003

• Olympus: EndoArm for Neurosurgery
  October 13, 2003

• Chuikyo Summarizes Discussions on Revision of Medical Fees
  October 13, 2003

• Korosho WG to Screen OTC Drugs for Sales Deregulation
  October 13, 2003

• So-net M3 to Have "MR-Kun" Enter the US Market
  October 6, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 570
• 571
• 572
• 573
• 574
• 575
• 576
• 577
• 578
• …
• Next ›
• 最終 »